Bile Duct Cancer Drug Market Report

Global and Region Bile Duct Cancer Drug Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：236
  • REPORT CODE：GMM1001254
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Bile Duct Cancer Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Bile Duct Cancer Drugmarket, defines the market attractiveness level of Bile Duct Cancer Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Bile Duct Cancer Drug industry, describes the types of Bile Duct Cancer Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Bile Duct Cancer Drug market and the development prospects and opportunities of Bile Duct Cancer Drug industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Bile Duct Cancer Drug market in Chapter 13.

    By Player:

    • Ariad Pharmaceuticals, Inc

    • Cellceutix Corporation

    • Blueprint Medicines Corporation

    • Celgene Corporation

    • Arrien Pharmaceuticals, LLC

    • Boehringer Ingelheim GmbH

    • Boston Biomedical, Inc

    • ArQule, Inc

    • Bristol-Myers Squibb Company

    • CellAct Pharma GmbH

    • Aslan Pharmaceuticals Pte Ltd

    • Concordia Healthcare Corp

    • Cellular Biomedicine Group, Inc

    • Bayer AG

    • Array BioPharma Inc

    • Bavarian Nordic A/S

    By Type:

    • Cabozantinib S-malate

    • Elpamotide

    • Exatecan Mesylate

    • LY-2801653

    • NUC-1031

    • Others

    By End-User:

    • Hospital

    • Clinic

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Bile Duct Cancer Drug Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Bile Duct Cancer Drug Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Bile Duct Cancer Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Bile Duct Cancer Drug Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Bile Duct Cancer Drug Market Analysis and Outlook to 2022

    • 7.1 Global Bile Duct Cancer Drug Consumption (2017-2022)

    • 7.2 United States Bile Duct Cancer Drug Consumption (2017-2022)

    • 7.3 Europe Bile Duct Cancer Drug Consumption (2017-2022)

    • 7.4 China Bile Duct Cancer Drug Consumption (2017-2022)

    • 7.5 Japan Bile Duct Cancer Drug Consumption (2017-2022)

    • 7.6 India Bile Duct Cancer Drug Consumption (2017-2022)

    • 7.7 South Korea Bile Duct Cancer Drug Consumption (2017-2022)

    8 Region and Country-wise Bile Duct Cancer Drug Market Analysis and Outlook to 2028

    • 8.1 Global Bile Duct Cancer Drug Consumption Forecast (2022-2028)

    • 8.2 United States Bile Duct Cancer Drug Consumption Forecast (2022-2028)

    • 8.3 Europe Bile Duct Cancer Drug Consumption Forecast (2022-2028)

    • 8.4 China Bile Duct Cancer Drug Consumption Forecast (2022-2028)

    • 8.5 Japan Bile Duct Cancer Drug Consumption Forecast (2022-2028)

    • 8.6 India Bile Duct Cancer Drug Consumption Forecast (2022-2028)

    • 8.7 South Korea Bile Duct Cancer Drug Consumption Forecast (2022-2028)

    9 Global Bile Duct Cancer Drug Market Outlook by Types and Applications to 2022

    • 9.1 Global Bile Duct Cancer Drug Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Cabozantinib S-malate Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Elpamotide Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Exatecan Mesylate Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global LY-2801653 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global NUC-1031 Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Bile Duct Cancer Drug Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Bile Duct Cancer Drug Market Outlook by Types and Applications to 2028

    • 10.1 Global Bile Duct Cancer Drug Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Cabozantinib S-malate Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Elpamotide Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Exatecan Mesylate Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global LY-2801653 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global NUC-1031 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Bile Duct Cancer Drug Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Bile Duct Cancer Drug Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Bile Duct Cancer Drug Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Bile Duct Cancer Drug Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Bile Duct Cancer Drug Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Bile Duct Cancer Drug Market Competitive Analysis

    • 14.1 Ariad Pharmaceuticals, Inc

      • 14.1.1 Ariad Pharmaceuticals, Inc Company Details

      • 14.1.2 Ariad Pharmaceuticals, Inc Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Ariad Pharmaceuticals, Inc Bile Duct Cancer Drug Product and Service

    • 14.2 Cellceutix Corporation

      • 14.2.1 Cellceutix Corporation Company Details

      • 14.2.2 Cellceutix Corporation Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Cellceutix Corporation Bile Duct Cancer Drug Product and Service

    • 14.3 Blueprint Medicines Corporation

      • 14.3.1 Blueprint Medicines Corporation Company Details

      • 14.3.2 Blueprint Medicines Corporation Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Blueprint Medicines Corporation Bile Duct Cancer Drug Product and Service

    • 14.4 Celgene Corporation

      • 14.4.1 Celgene Corporation Company Details

      • 14.4.2 Celgene Corporation Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Celgene Corporation Bile Duct Cancer Drug Product and Service

    • 14.5 Arrien Pharmaceuticals, LLC

      • 14.5.1 Arrien Pharmaceuticals, LLC Company Details

      • 14.5.2 Arrien Pharmaceuticals, LLC Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Arrien Pharmaceuticals, LLC Bile Duct Cancer Drug Product and Service

    • 14.6 Boehringer Ingelheim GmbH

      • 14.6.1 Boehringer Ingelheim GmbH Company Details

      • 14.6.2 Boehringer Ingelheim GmbH Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Boehringer Ingelheim GmbH Bile Duct Cancer Drug Product and Service

    • 14.7 Boston Biomedical, Inc

      • 14.7.1 Boston Biomedical, Inc Company Details

      • 14.7.2 Boston Biomedical, Inc Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Boston Biomedical, Inc Bile Duct Cancer Drug Product and Service

    • 14.8 ArQule, Inc

      • 14.8.1 ArQule, Inc Company Details

      • 14.8.2 ArQule, Inc Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 ArQule, Inc Bile Duct Cancer Drug Product and Service

    • 14.9 Bristol-Myers Squibb Company

      • 14.9.1 Bristol-Myers Squibb Company Company Details

      • 14.9.2 Bristol-Myers Squibb Company Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Bristol-Myers Squibb Company Bile Duct Cancer Drug Product and Service

    • 14.10 CellAct Pharma GmbH

      • 14.10.1 CellAct Pharma GmbH Company Details

      • 14.10.2 CellAct Pharma GmbH Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 CellAct Pharma GmbH Bile Duct Cancer Drug Product and Service

    • 14.11 Aslan Pharmaceuticals Pte Ltd

      • 14.11.1 Aslan Pharmaceuticals Pte Ltd Company Details

      • 14.11.2 Aslan Pharmaceuticals Pte Ltd Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Aslan Pharmaceuticals Pte Ltd Bile Duct Cancer Drug Product and Service

    • 14.12 Concordia Healthcare Corp

      • 14.12.1 Concordia Healthcare Corp Company Details

      • 14.12.2 Concordia Healthcare Corp Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Concordia Healthcare Corp Bile Duct Cancer Drug Product and Service

    • 14.13 Cellular Biomedicine Group, Inc

      • 14.13.1 Cellular Biomedicine Group, Inc Company Details

      • 14.13.2 Cellular Biomedicine Group, Inc Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Cellular Biomedicine Group, Inc Bile Duct Cancer Drug Product and Service

    • 14.14 Bayer AG

      • 14.14.1 Bayer AG Company Details

      • 14.14.2 Bayer AG Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Bayer AG Bile Duct Cancer Drug Product and Service

    • 14.15 Array BioPharma Inc

      • 14.15.1 Array BioPharma Inc Company Details

      • 14.15.2 Array BioPharma Inc Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Array BioPharma Inc Bile Duct Cancer Drug Product and Service

    • 14.16 Bavarian Nordic A/S

      • 14.16.1 Bavarian Nordic A/S Company Details

      • 14.16.2 Bavarian Nordic A/S Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Bavarian Nordic A/S Bile Duct Cancer Drug Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Bile Duct Cancer Drug

    • Figure Bile Duct Cancer Drug Picture

    • Table Global Bile Duct Cancer Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Bile Duct Cancer Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Bile Duct Cancer Drug Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Bile Duct Cancer Drug Consumption by Country (2017-2022)

    • Figure United States Bile Duct Cancer Drug Consumption and Growth Rate (2017-2022)

    • Table Europe Bile Duct Cancer Drug Consumption and Growth Rate (2017-2022)

    • Figure China Bile Duct Cancer Drug Consumption and Growth Rate (2017-2022)

    • Figure Japan Bile Duct Cancer Drug Consumption and Growth Rate (2017-2022)

    • Figure India Bile Duct Cancer Drug Consumption and Growth Rate (2017-2022)

    • Figure South Korea Bile Duct Cancer Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Bile Duct Cancer Drug Consumption Forecast by Country (2022-2028)

    • Figure United States Bile Duct Cancer Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Bile Duct Cancer Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Bile Duct Cancer Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Bile Duct Cancer Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Bile Duct Cancer Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Bile Duct Cancer Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cabozantinib S-malate Consumption and Growth Rate (2017-2022)

    • Figure Global Elpamotide Consumption and Growth Rate (2017-2022)

    • Figure Global Exatecan Mesylate Consumption and Growth Rate (2017-2022)

    • Figure Global LY-2801653 Consumption and Growth Rate (2017-2022)

    • Figure Global NUC-1031 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Cabozantinib S-malate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Elpamotide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Exatecan Mesylate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global LY-2801653 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global NUC-1031 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Bile Duct Cancer Drug Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Bile Duct Cancer Drug Export by Region (Top 5 Countries) (2017-2028)

    • Table Ariad Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Ariad Pharmaceuticals, Inc Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ariad Pharmaceuticals, Inc Bile Duct Cancer Drug Product and Service

    • Table Cellceutix Corporation (Foundation Year, Company Profile and etc.)

    • Table Cellceutix Corporation Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cellceutix Corporation Bile Duct Cancer Drug Product and Service

    • Table Blueprint Medicines Corporation (Foundation Year, Company Profile and etc.)

    • Table Blueprint Medicines Corporation Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Blueprint Medicines Corporation Bile Duct Cancer Drug Product and Service

    • Table Celgene Corporation (Foundation Year, Company Profile and etc.)

    • Table Celgene Corporation Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Corporation Bile Duct Cancer Drug Product and Service

    • Table Arrien Pharmaceuticals, LLC (Foundation Year, Company Profile and etc.)

    • Table Arrien Pharmaceuticals, LLC Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Arrien Pharmaceuticals, LLC Bile Duct Cancer Drug Product and Service

    • Table Boehringer Ingelheim GmbH (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim GmbH Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim GmbH Bile Duct Cancer Drug Product and Service

    • Table Boston Biomedical, Inc (Foundation Year, Company Profile and etc.)

    • Table Boston Biomedical, Inc Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boston Biomedical, Inc Bile Duct Cancer Drug Product and Service

    • Table ArQule, Inc (Foundation Year, Company Profile and etc.)

    • Table ArQule, Inc Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table ArQule, Inc Bile Duct Cancer Drug Product and Service

    • Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Company Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Company Bile Duct Cancer Drug Product and Service

    • Table CellAct Pharma GmbH (Foundation Year, Company Profile and etc.)

    • Table CellAct Pharma GmbH Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table CellAct Pharma GmbH Bile Duct Cancer Drug Product and Service

    • Table Aslan Pharmaceuticals Pte Ltd (Foundation Year, Company Profile and etc.)

    • Table Aslan Pharmaceuticals Pte Ltd Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aslan Pharmaceuticals Pte Ltd Bile Duct Cancer Drug Product and Service

    • Table Concordia Healthcare Corp (Foundation Year, Company Profile and etc.)

    • Table Concordia Healthcare Corp Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Concordia Healthcare Corp Bile Duct Cancer Drug Product and Service

    • Table Cellular Biomedicine Group, Inc (Foundation Year, Company Profile and etc.)

    • Table Cellular Biomedicine Group, Inc Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cellular Biomedicine Group, Inc Bile Duct Cancer Drug Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Bile Duct Cancer Drug Product and Service

    • Table Array BioPharma Inc (Foundation Year, Company Profile and etc.)

    • Table Array BioPharma Inc Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Array BioPharma Inc Bile Duct Cancer Drug Product and Service

    • Table Bavarian Nordic A/S (Foundation Year, Company Profile and etc.)

    • Table Bavarian Nordic A/S Bile Duct Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bavarian Nordic A/S Bile Duct Cancer Drug Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US